Epigenetic reprogramming represents a "Wright Brothers moment" for medicine, with human clinical trials for blindness using a subset of Yamanaka genes currently imminent. This technology aims to reset cellular age rather than merely treating symptoms, demonstrating potential for reversing age-related decline in tissues ranging from the brain and immune system to joints and kidneys. Beyond viral delivery systems, research is shifting toward small-molecule cocktails to reduce costs and increase accessibility for global populations. The current scientific funding model often stifles radical innovation, necessitating alternative approaches like the "Friends of Sinclair Lab" to accelerate high-risk, high-reward research. Personal longevity protocols emphasize strict glucose management, specific supplements like NMN and natto kinase, and lifestyle adjustments, including stress reduction and the elimination of alcohol, to maintain healthspan and achieve biological age reversal.
Sign in to continue reading, translating and more.
Continue
